Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 1/20 | 0.76 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.62 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.61 |
| ▸ | TNKS | O95271 | 1/20 | 0.61 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.61 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.61 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.61 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.61 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.61 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.61 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.61 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.61 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.61 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.61 |
| ▸ | SLC6A19 | Q695T7 | 1/20 | 0.59 |
| ▸ | BACE1 | P56817 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31320929 | 1.00 | HSD17B3 (0.76) | HSD17B3NPSR1HDAC3TNKSHDAC4 | |
| SCHEMBL236623 | 1.00 | HSD17B3 (0.76) | HSD17B3NPSR1HDAC3TNKSHDAC4 | |
| SCHEMBL8937628 | 1.00 | HSD17B3 (0.76) | HSD17B3NPSR1HDAC3TNKSHDAC4 | |
| SCHEMBL11470768 | 0.98 | HSD17B3 (0.73) | HSD17B3NPSR1HDAC3TNKSHDAC4 | |
| Hydrochloric Acid SCHEMBL6818198 | 0.98 | HSD17B3 (0.73) | HSD17B3NPSR1HDAC3TNKSHDAC4 | |
| SCHEMBL1035544 | 0.86 | HSD17B3 (0.79) | HSD17B3NPSR1SLC6A19BACE1CYP2D6 | |
| SCHEMBL1035543 | 0.86 | HSD17B3 (0.79) | HSD17B3NPSR1SLC6A19BACE1CYP2D6 | |
| SCHEMBL271386 | 0.86 | NPSR1 (0.74) | HSD17B3NPSR1HDAC3TNKSHDAC4 | |
| SCHEMBL69146 | 0.86 | NPSR1 (0.74) | HSD17B3NPSR1HDAC3TNKSHDAC4 | |
| SCHEMBL29162914 | 0.85 | HSD17B3 (0.71) | HSD17B3NPSR1SLC6A19BACE1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 521 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| CN-117430128-B | Preparation method and application of copper-doped ZSM-5 zeolite molecular sieve containing mesoporous structure | 常州大学 | 2025-04-25 | — | — | CN | claimed |
| CN-117430125-B | Preparation method and application of manganese doped mesoporous structure-containing acidic Beta zeolite molecular sieve | 常州大学 | 2025-03-21 | — | — | CN | claimed |
| CN-118955813-A | Low-temperature early-strength water reducer and preparation method thereof | 北京工业大学 | 2024-11-15 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-117430125-A | Preparation method and application of manganese doped mesoporous structure-containing acidic Beta zeolite molecular sieve | 常州大学 | 2024-01-23 | — | — | CN | claimed |
| CN-117430128-A | Preparation method and application of copper-doped ZSM-5 zeolite molecular sieve containing mesoporous structure | 常州大学 | 2024-01-23 | — | — | CN | claimed |
| CN-115925743-A | Method for preparing (2-oxo-2-aryl ethyl) diaryl phosphine oxide compound | 湖南理工学院 | 2023-04-07 | — | — | CN | claimed |
| CN-109265458-B | Matrine-based antitumor drug compound | 中国医学科学院药用植物研究所 | 2020-09-15 | — | — | CN | claimed |
| CN-109265458-A | A kind of antineoplastic compounds based on matrine | 中国医学科学院药用植物研究所 | 2019-01-25 | — | — | CN | claimed |
| US-20060020141-A1 | Metallized dye | XEROX CORPORATION | 2006-01-26 | — | — | US | claimed |
| US-20060000778-A1 | high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers | MCMASTER UNIVERSITY (CA) | 2006-01-05 | — | — | US | claimed |
| WO-2005102503-A1 | PERVAPORATION COMPOSITE MEMBRANES | MCMASTER UNIVERSITY (CA) | 2005-11-03 | — | — | WO | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| CN-1655057-A | Photosensitive semiconductor nanocrystals, photosensitive composition comprising semiconductor nanocrystals and uses thereof | SAMSUNG ELECTRONICS CO LTD (KR) | 2005-08-17 | — | — | CN | claimed |
| US-20050161666-A1 | Photosensitive semiconductor nanocrystals, photosensitive composition comprising semiconductor nanocrystals and method for forming semiconductor nanocrystal pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2005-07-28 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-1526584-A2 | Photosensitive semiconductor nanocrystals, photosensitive composition comprising semiconductor nanocrystals and method for forming semiconductor nanocrystal pattern using the same | Samsung Electronics Co., Ltd (KR) | 2005-04-27 | — | — | EP | claimed |
| EP-1015505-B1 | PRODUCTION OF PHOTOPOLYMERIZED POLYESTER HIGH INDEX OPHTHALMIC LENSES | SIGNET ARMORLITE INC (US) | 2005-03-09 | — | — | EP | claimed |
| EP-0783710-B1 | POLYESTER RESIN-BASED HIGH INDEX OPHTHALMIC LENSES HAVING IMPROVED OPTICAL UNIFORMITY AND/OR TINTABILITY | SIGNET ARMORLITE INC (US) | 2002-05-29 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060020141-A1 | Metallized dye | CDYL, CDY1; CDY1B, CDYL2 | HSD17B3 2354/4885NPSR1 2989/4885HDAC3 1033/4885 |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | HSD17B3 4158/4885NPSR1 3033/4885HDAC3 849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.